Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Current Leases (2016 - 2025)

Pharma-Bio Serv's Current Leases history spans 15 years, with the latest figure at $28834.0 for Q4 2025.

  • For Q4 2025, Current Leases fell 82.55% year-over-year to $28834.0; the TTM value through Oct 2025 reached $28834.0, down 82.55%, while the annual FY2025 figure was $28834.0, 82.55% down from the prior year.
  • Current Leases reached $28834.0 in Q4 2025 per PBSV's latest filing, down from $71362.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $172957.0 in Q3 2021 to a low of $28834.0 in Q4 2025.
  • Average Current Leases over 5 years is $139339.6, with a median of $147954.0 recorded in 2023.
  • Peak YoY movement for Current Leases: skyrocketed 1390.63% in 2021, then tumbled 82.55% in 2025.
  • A 5-year view of Current Leases shows it stood at $130060.0 in 2021, then rose by 8.3% to $140855.0 in 2022, then grew by 8.25% to $152474.0 in 2023, then grew by 8.35% to $165201.0 in 2024, then crashed by 82.55% to $28834.0 in 2025.
  • Per Business Quant, the three most recent readings for PBSV's Current Leases are $28834.0 (Q4 2025), $71362.0 (Q3 2025), and $113044.0 (Q2 2025).